FluoroPharma Medical, Inc.
FPMI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.85K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6,852.00 |
|---|---|
| Enterprise Value | $6.22 Million |
| Earnings per Share | $-0.06 |
| Beta | 0.09 |
| Outstanding Shares | 34,026,541 |
Return
| Return on Equity | 20.14% |
|---|---|
| Return on Assets | -612.34% |
| Return on Invested Capital | 21.61% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.83 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.61 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About FluoroPharma Medical, Inc.
4 employees
CEO: Edward L. Lyons Jr.
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications wit...